Insulin plus growth factor inhibitor limits vision damage in diabetic mice
Monday, December 17, 2012 - 19:30
in Health & Medicine
A new therapeutic approach to diabetes that combines insulin and an inhibitor of the epidermal growth factor (EGF) betacellulin could limit the progression of diabetic macular edema (DME), researchers report.